Daiken Biomedical Co., Ltd. (TPE:7780)

Taiwan · Delayed Price · Currency is TWD

18.25

+0.05 (0.27%)

At close: Jun 24, 2026

-1.35% (1Y)

Market Cap	14.70B +53.1%
Revenue (ttm)	2.02B +39.0%
Net Income	337.22M +39.0%
EPS	0.47 +4.7%
Shares Out	810.02M
PE Ratio	38.74
Forward PE	n/a
Dividend	0.70 (3.83%)
Ex-Dividend Date	Jun 22, 2026

Volume	1,115,637
Open	18.20
Previous Close	18.20
Day's Range	18.05 - 18.55
52-Week Range	16.00 - 40.10
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 6, 2026

About Daiken Biomedical

Daiken Biomedical Co., Ltd. engages in the research and development of healthy food products. The company was founded in 2018 and is based in Taipei, Taiwan. Daiken Biomedical Co., Ltd. operates as a subsidiary of Sunfun Info Co., Ltd. [Read more]

Industry Packaged Foods

Sector Consumer Staples

Founded 2018

Employees 20

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 7780

Full Company Profile

Financial Performance

In 2025, Daiken Biomedical's revenue was 1.90 billion, an increase of 39.10% compared to the previous year's 1.36 billion. Earnings were 337.87 million, an increase of 217.01%.

Financial Statements